Andere Sprachen CareDx, Inc

Aktien

A118WG

US14167L1035

CDNA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
7,98 ^USD	-3,04 %		-3,62 %	-33,50 %

16.04.	CareDx, Inc. ernennt John W. Hanna zum Vorstandsvorsitzenden	CI
16.04.	CareDx, Inc. ernennt John W. Hanna zum Präsidenten und Mitglied des Board of Directors	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	19.04.
CareDx Appoints John Hanna as CEO, President	16.04.
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer	16.04.
CareDx, Inc Appoints John W. Hanna as Chief Executive Officer	16.04.
CareDx, Inc Appoints John W. Hanna as President and Member of the Board of Directors	16.04.
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	09.04.
CareDx et ses collaborateurs présentent les dernières avancées dans le domaine cardio-thoracique lors de la réunion 2024 de la Société internationale de transplantation cardiaque et pulmonaire	09.04.
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting	09.04.
CareDx Appoints Bryan Riggsbee to Its Board of Directors	11.03.
CareDx, Inc Appoints Bryan Riggsbee to Its Board of Directors	11.03.
CareDx : Appoints Bryan Riggsbee to Its Board of Directors - Form 8-K	11.03.
CareDx : Corporate Presentation February 2024	01.03.
CareDx: Q4 Earnings Snapshot	28.02.
Earnings Flash (CDNA) CAREDX Reports Q4 Revenue $65.6M, vs. Street Est of $64.1M	28.02.
CareDx, Inc Provides Revenue Guidance for the Full Year of 2024	28.02.
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results	28.02.
CareDx, Inc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28.02.
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference	27.02.
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results	21.02.
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings	21.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CareDx, Inc

Aktien

A118WG

US14167L1035

CDNA

Andere Sprachen

Filter